Testosterone is having a moment at the Department of Health and Human Services.
Late last year, the Food and Drug Administration convened an expert panel to discuss easing access to testosterone replacement therapy, including the prospect of removing the hormone from the list of scheduled, or restricted, substances and taking the black box warning off testosterone products. Shortly after, Adm. Brian Christine — a urologist and men’s health expert — was sworn in as assistant secretary for health, and WIRED reported that a National Men’s Initiative may be on the way.
